封面
市场调查报告书
商品编码
1981779

透过生物技术製程实现化妆品的生物特性活性

Bio-Identical Actives in Cosmetics via Biotechnological Processes

出版日期: | 出版商: Frost & Sullivan | 英文 61 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球对永续和高效成分的需求正在推动以科学为先的新一代化妆品创新。

合成生物学、精准发酵、无细胞生物製造和人工智慧驱动的分子发现技术的进步正在从根本上改变全球生物同源化妆品活性成分市场。这些技术永续且强大的原料,例如重组胶原蛋白、客製化胜肽、微生物后生元和发酵衍生脂质。监管机构和市场对永续性、可追溯性、珊瑚礁安全以及逐步淘汰动物源和石油源原料的关注,正在加速这些新一代活性成分在护肤、皮肤化妆品以及美容与健康混合领域的应用。全球研究活动蓬勃发展,专利申请、同行评审出版物以及涵盖皮肤病学、微生物组学、计算生物学和生物製造等领域的跨学科创新均显着增加。

本报告全面评估了生物同源化妆品活性成分的技术、监管和商业性发展历程,涵盖了从人工智慧设计的胜肽到突破性技术(例如源自极端微生物的UV防晒过滤剂)等各个方面。此外,报告重点介绍了关键创新者、新兴经营模式和高价值成长机会,为希望在未来生物技术主导的化妆品生态系统中占据领先地位的利益相关人员提供了策略性主导。 (註:本研究不包含市场规模预测,重点在于科学、技术和应用层面的进步。)

技术平台:

  • 精准发酵
  • 微藻类和蓝菌发酵平台
  • 酵素和无细胞生物催化剂
  • 合成生物学和代谢工程平台

成分类别:

  • 重组蛋白和胜肽(胶原蛋白、信号肽)
  • 发酵衍生的多醣体(玻尿酸、聚醣)
  • 生物等效脂质(角鲨烷、神经酰胺)
  • 生物发酵产生的抗氧化剂和类胡萝卜素
  • 源自植物细胞培养的活性成分(多酚、糖苷、植物代谢物)

目录

策略要务

  • 为什么经济成长变得越来越困难?
  • 策略要务八要素™:阻碍成长的因素
  • 三大策略要务对化妆品中生物同源活性成分的影响
  • 成长机会能否推动「成长管道引擎™」的发展?
  • 调查方法

成长机会分析

  • 分析范围
  • 调查细分
  • 化妆品中的生物活性:概述
  • 传统生物活性成分萃取方法面临的挑战以及对生物技术手段的需求
  • 促进全球接受生物同源活性成分的监管和安全条件

成长要素

  • 成长驱动因素
  • 成长抑制因素

化妆品中生物同源活性成分的技术进步

  • 生物同源性化妆品活性成分类别的发展趋势
  • 利用发酵衍生的多醣体改善化妆品的保湿和补水性能。
  • 与传统替代品相比,生物基抗氧化剂和类胡萝卜素可提供更优异的皮肤保护。
  • 利用生物技术製程提高高性能重组蛋白和胜肽的生产效率。
  • 生物同源脂质可改善护肤中的屏障修復方案
  • 利用植物细胞培养技术实现稀有植物化学活性成分的永续生产途径
  • 生物同源化妆品活性成分的技术趋势
  • 利用精准发酵技术,透过可程式设计生物製造实现高价值客製化活性成分的生产
  • 利用微藻类和蓝菌发酵平台进行可扩展的生物生产,展现了经济效益。
  • 利用酵素和无细胞生物催化剂实现清洁、目标导向的活性成分合成。
  • 引领下一代化妆品活性成分发展的合成生物学和代谢工程平台。

创新生态系统

  • 生物同源化妆品活性成分的商业化表明,人们明显偏好发酵方法。
  • 与活性成分向生物技术製程过渡相一致的合作与策略伙伴关係。
  • 投资活动旨在促进生物同源活性成分在先进化妆品配方中的应用和推广。

智慧财产权发展趋势(2020-2025)

  • 为了满足活性成分生产流程改善的需求,全球专利申请活动正在增加。
  • 支持生物同源性化妆品活性成分增长的研究活动

分析师意见

  • 加强商业和研究倡议,以改进合成生物学平台,用于客製化生物同源活性成分。
  • 先进的生物技术製程正在推动下一代生物同源化妆品活性成分的研发。

成长机会领域

  • 成长机会 1:用于发现新型化妆品胜肽和生物同源活性成分的人工智慧平台
  • 成长机会2:用于按需生产化妆品活性成分的无细胞生物製造
  • 成长机会3:微生物组衍生的讯号分子

附录

  • 技术成熟度等级 (TRL):描述

下一步

  • 成长机会的益处和影响
  • 下一步
  • 免责声明
简介目录
Product Code: DB67

Global Demand for Sustainable and Effective Ingredients Leading the Way for a New Generation of Science-First Cosmetic Innovations

The global market for bio-identical cosmetic actives is undergoing a structural transformation driven by advances in synthetic biology, precision fermentation, cell-free biomanufacturing, and AI-enabled molecule discovery. These technologies are enabling the production of highly targeted, sustainable, and functionally superior ingredients such as recombinant collagen, designer peptides, microbial postbiotics, and fermentation-derived lipids. Regulatory and market pressures centered on sustainability, traceability, reef safety, and the phase-down of animal- and petro-derived inputs are accelerating the adoption of these next-generation actives across skincare, dermocosmetics, and hybrid beauty-wellness categories. Research intensity is rising globally, with a notable increase in patents, peer-reviewed publications, and cross-disciplinary innovation spanning dermatology, microbiome science, computational biology, and biomanufacturing.

This report provides a comprehensive assessment of the technological, regulatory, and commercial evolution of bio-identical cosmetic actives, mapping breakthroughs from AI-designed peptides to extremophile-derived UV filters. It further highlights key innovators, emerging business models, and high-value growth opportunities, offering strategic insights for stakeholders seeking leadership in the future biotech-driven beauty ecosystem. (Note: This research excludes market sizing and forecasting. The focus will be on scientific, technological, and application-level advancements.)

Technology Platforms:

  • Precision Fermentation
  • Microalgae and Cyanobacteria Fermentation Platforms
  • Enzymatic and Cell-Free Biocatalysis
  • Synthetic Biology & Metabolic Engineering Platforms

Ingredient Categories:

  • Recombinant Proteins and Peptides (Collagen, Signal Peptides)
  • Fermentation-Derived Polysaccharides (Hyaluronic Acid, Glycans)
  • Bio-Identical Lipids (Squalane, Ceramides)
  • Bio-Fermented Antioxidants and Carotenoids
  • Plant-Cell-Culture Actives (Polyphenols, Glycosides, Botanical Metabolites)

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8TM: Factors Creating Pressure on Growth
  • The Impact of the Top 3 Strategic Imperatives on the Bio-Identical Actives in Cosmetics
  • Growth Opportunities Fuel the Growth Pipeline EngineTM
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Research Segmentation
  • Bio-Identical Actives in Cosmetics: Overview
  • Challenges in Conventional Extraction of Biological Actives Resulting in the Need for Biotechnological Approaches
  • Regulatory & Safety Landscape Promoting Global Acceptance of Bio-Identical Actives

Growth Generator

  • Growth Drivers
  • Growth Restraints

Technology Advancements in Bio-Identical Actives in Cosmetics

  • Trends in Bio-Identical Cosmetic Active Ingredient Categories
  • Fermentation-Derived Polysaccharides Improving Hydration and Moisturization of Cosmetic Products
  • Bio-Based Antioxidants & Carotenoids Providing Better Skin Defense Compared to Conventional Alternatives
  • Biotechnological Processes Improve Ease of Production for High Performance Recombinant Proteins and Peptides
  • Bio-Identical Lipids Improving Barrier Repair Solutions in Skincare
  • Plant Cell Culture Providing a Sustainable Route for Producing Rare Phytochemical Actives
  • Technology Trends in Bio-Identical Cosmetic Actives
  • Programmable Biomanufacturing with Precision Fermentation Enabling Production of High-Value Designer Actives
  • Scalable Bioproduction with Microalgae and Cyanobacteria Fermentation Platforms Proving to be Economically Efficient
  • Enzymatic and Cell-Free Biocatalysis Enabling Clean, Targeted Active Ingredient Synthesis
  • Synthetic Biology & Metabolic Engineering Platforms to Lead the Way for the Next Generation of Cosmetic Actives

Innovation Ecosystem

  • Bio-Identical Cosmetic Active Commercialization Activities Indicates Clear Preference for Fermentation Methods
  • Collaborations and Strategic Partnerships Aligned with Shift to Biotechnological Processes for Actives
  • Investment Activities Fueling the Growth and Adoption of Bio-Identical Actives for Advanced Cosmetic Formulations

IP Landscaping (2020-2025)

  • Patent Filing Activities Growing Globally to Meet the Needs for Improved Processes for Active Ingredients
  • Research Activities Supporting the Growth of Bio-Identical Cosmetic Actives

Analyst Perspective

  • Commercial & Research Initiatives to Intensify in Improving Synthetic Biology Platforms for Customized Bio-Identical Actives
  • Advanced Biotechnological Processes Leading the Way Forward for the Next Generation of Bio-Identical Cosmetic Actives

Growth Opportunity Universe

  • Growth Opportunity 1: AI-Powered Discovery Platforms for Novel Cosmetic Peptides and Bio-Identical Actives
  • Growth Opportunity 2: Cell-Free Biomanufacturing for On-Demand Cosmetic Active Production
  • Growth Opportunity 3: Microbiome-Derived Signaling Molecules

Appendix

  • Technology Readiness Levels (TRL): Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer